Lv3
358 积分 2025-07-26 加入
Evolution to complex karyotype disease in mono-allelic TP53-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
6天前
已完结
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
6天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
24天前
已完结
The world apheresis association registry, 2023 update
2个月前
已完结
Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia
3个月前
已完结
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
3个月前
已完结
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
3个月前
已完结
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:
3个月前
已完结
Results of Intensive Chemotherapy in 998 Patients Aged 65 Years or Older with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Predictive Prognostic Models for Outcome
3个月前
已关闭
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
3个月前
已完结
皖公网安备34019202002308
